Advantages of C2 Monitoring to Avoid Acute Rejection in Pediatric Heart Transplant Recipients

This publication has 38 references indexed in Scilit:

• Best Single Time Points to Predict the Area-Under-the-Curve in Long-Term Heart Transplant Patients Taking Mycophenolate Mofetil in Combination with Cyclosporine or Tacrolimus
  The Journal of Heart and Lung Transplantation, 2005
• Monitoring of Cyclosporine 2-Hour Post-Dose Levels in Heart Transplantation: Improvement in Clinical Outcomes
  The Journal of Heart and Lung Transplantation, 2005
• Enhanced clinical utility of De Novo cyclosporine C2 monitoring after lung transplantation
  The Journal of Heart and Lung Transplantation, 2004
• Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation
  Pediatric Nephrology, 2004
• Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients
  Clinical Biochemistry, 2004
• Evaluation of myocardial performance index to predict mild rejection in cardiac transplantation
  Clinical Cardiology, 2004
• Correlation between neoral 2 hours post-dose levels and histologic findings on surveillance biopsies
  Transplantation Proceedings, 2004
• Immunosuppression in pediatric heart transplantation: 2003 and beyond
  Current Treatment Options in Cardiovascular Medicine, 2003
• Evaluation abnormer Myokardwandgeschwindigkeiten des univentrikul ren Herzens mittels Gewebedoppler-Echokardiographie
  Clinical Research in Cardiology, 2003
• Pharmacokinetics of Cyclosporine after Renal Transplant in Children
  The Journal of Clinical Pharmacology, 1996